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Abstract
Cognitive reserve among highly intelligent older individuals makes detection of early Alzheimer’s disease (AD)
difficult. We tested the hypothesis that mild memory impairment determined by IQ-adjusted norms is associated
with single photon emission computed tomography (SPECT) perfusion abnormality at baseline and predictive of
future decline. Twenty-three subjects with a Clinical Dementia Rating (CDR) score of 0, were reclassified after
scores were adjusted for IQ into two groups, 10 as having mild memory impairments for ability (IQ-MI) and 13 as
memory-normal (IQ-MN). Subjects underwent cognitive and functional assessments at baseline and annual
follow-up for 3 years. Perfusion SPECT was acquired at baseline. At follow-up, the IQ-MI subjects demonstrated
decline in memory, visuospatial processing, and phonemic fluency, and 6 of 10 had progressed to a CDR of 0.5,
while the IQ-MN subjects did not show decline. The IQ-MI group had significantly lower perfusion than the IQ-MN
group in parietal0precuneus, temporal, and opercular frontal regions. In contrast, higher perfusion was observed in
IQ-MI compared with IQ-MN in the left medial frontal and rostral anterior cingulate regions. IQ-adjusted memory
impairment in individuals with high cognitive reserve is associated with baseline SPECT abnormality in a pattern
consistent with prodromal AD and predicts subsequent cognitive and functional decline. (JINS, 2007, 13, 821–831.)
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INTRODUCTION
As disease-modifying treatments become available, the best
hope for altering the progression of Alzheimer’s disease
(AD) is the identification of individuals in the very earliest
stages of the disease. However, the task of differentiating
normal, age-related memory changes from early symptoms
ofAD is difficult, particularly among individuals with high
cognitive reserve.
It has been widely acknowledged that the trajectory of
clinical decline leading to AD passes through a stage of
mildcognitiveimpairment(MCI;Petersenetal.,1999;Win-
blad et al., 2004) that may begin years before overt demen-
tia. Recent reports indicate that the neuropathologic changes
ofAD,includingneurofibrillarytanglesandamyloidplaques,
not only occur in MCI (Markesbery et al., 2006; Petersen
et al., 2006) but are also found in some individuals who are
clinically normal (Bennett et al., 2006; Davis et al., 1999;
Morris et al., 1996, 2001; Price & Morris, 1999; Storandt
et al., 2006). While diagnostic and imaging markers are
being developed to detect early pathologic changes during
life (Andreasen & Blennow, 2005; Klunk et al., 2003, 2004;
Schoonenboom et al., 2005), clinical performance on tests
of memory remains the most widely accepted marker of
prodromal AD in at-risk individuals (Albert et al., 2001;
Albert, 2002).
However, highly intelligent individuals with higher cog-
nitive reserve (Stern, 2002, 2006) tend to perform well on
cognitivetestsdespiteneuropathologicalevidenceofadvanc-
ing AD pathology (Mortimer et al., 2005; Naugle et al.,
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8211990;Richards&Deary,2005;Whalleyetal.,2004).Neuro-
imaging studies of individuals with high cognitive reserve
found that these individuals tend to recruit alternate neural
networks or establish compensatory pathways in response
to neuropsychological task demands (Cabeza et al., 2002;
Mortimer et al., 2005; Stern et al., 2005).To account for the
influence of cognitive reserve on neuropsychological test
performance, we explored whether IQ-adjustments could
detect early memory changes (IQ-MI) possibly masked by
cognitive reserve and whether single photon emission com-
puted tomography (SPECT) perfusion differed between
groups with normal and impaired IQ-adjusted scores.
Functional neuroimaging methods such as positron emis-
sion tomography (PET) and SPECT are used increasingly
intheclinicalevaluationofindividualswithmemoryimpair-
ment. These methods may have limited specificity with
respect to non-AD causes of dementia (Rutschmann & Mat-
char, 2002); however, image abnormalities have been
reported in the prodromal phase of AD, reflecting early
changes in brain physiology that have now been shown to
portend further decline (Johnson et al., 1998, 2007; Mun-
gas et al., 2002). For example, temporoparietal hypoperfu-
sion has been reported in nondemented subjects with
cognitive impairment who later converted to AD (Chetelat
et al., 2003; Johnson & Albert, 2000; Nestor et al., 2003),
and in asymptomatic carriers of the PS1 gene mutation with
autosomal dominant inheritance, which causes early onset
AD (Johnson et al., 2001). In this study, our objective was
to investigate whether individuals identified as IQ-MI
showed evidence of functional imaging abnormalities at
baseline and a higher likelihood of subsequent declines in
cognitionanddailylivingskills.WehypothesizedthatIQ-MI
subjects with a Clinical Dementia Rating score of 0 (CDR0)
at baseline would show SPECT hypoperfusion in temporo-
parietal regions consistent with those subjects who later
converted to AD (Johnson & Albert, 2000). We, further-
more,hypothesizedthatIQ-MIsubjectswouldbemorelikely
to decline on neuropsychological and functional measures
(CDR) 3 years later than those without evidence of impair-
ment after IQ-adjustment (IQ-MN).
METHODS
Research Participants
Subjects were recruited from a cohort of 293 community-
dwelling individuals who answered newspaper advertise-
ments to participate in an aging and Alzheimer’s disease
study at Brigham and Women’s Hospital. The study was
annually approved byThe Institutional Review Board, Part-
ners Human Research Committee, in accordance with the
Helsinki Declaration, and participants gave informed con-
sent. All subjects were living independently and agreed to
return for follow-up testing. They underwent a series of
neuropsychological tests commonly used in the assessment
of older individuals (Rentz & Weintraub, 1999), which
included the Blessed Dementia Rating Scale (BDS; Blessed
et al., 1968); Geriatric Depression Scale (GDS; Yesavage
et al., 1983); American National Adult Reading Test
(AMNART; Ryan & Paolo, 1992); Clinical Dementia Rat-
ing Scale (CDR; Morris, 1993); word generation to the let-
ters F, A, and S (Monsch et al., 1992); category fluency to
animals, fruits, and vegetables (CAT; Monsch et al., 1992);
the 6-trial version of the Selective Reminding Test (SRT;
Masur et al., 1989); the 60-item version of the Boston Nam-
ing Test (BNT; Kaplan et al., 1983; Tombaugh & Hubley,
1997); and the Visual Form Discrimination Test (VFDT;
Benton et al., 1983). They also underwent a comprehensive
medical and psychiatric interview as well as a neurological
evaluation to rule out any major neurological disorders that
might contribute to cognitive dysfunction. None of the par-
ticipants had a history of alcoholism, drug abuse, or evi-
dence of neurological, medical, or psychiatric illness.
From a total of 81 subjects who underwent SPECT, 23
subjects were selected for this analysis because they met
the following inclusion criteria: (1) a CDR score of 0, (2)
an estimated IQ of 120 or greater on the AMNART, (3)
baseline scores on the BDS of less than 2, (4) a GDS score
in the normal range (score , 11), (5) cognitive test scores
within 1.5 SD from the mean on the basis of published test
norms adjusted for age and education (see Table 1), and (6)
twoE3allelesbecauseE4hasbeenassociatedwithincreased
risk for the development of AD and is also associated with
regionally reduced cerebral metabolism (Caselli et al., 2004;
Reiman et al., 2001, 2005; Small, 2002). We also excluded
all subjects with an E2 allele as this allele has been linked
to a reduced risk for AD (Hyman et al., 1996). All 23 sub-
jectshadastructuralmagneticresonanceimagingscanwithin
3 months of their SPECT scan.
Estimating Cognitive Reserve
The cognitive reserve hypothesis postulates that individu-
als with higher reserve may have AD pathology but not
exhibit cognitive impairment (Bennett et al., 2006; Stern
et al., 2005). Factors such as education (Stern et al., 1994),
occupational status (Stern et al., 1995), life activities (Scar-
meas et al., 2003), innate intelligence (Alexander et al.,
1997), or a combination of these factors (Andel et al., 2006;
Stern et al., 2005) are thought to compose aspects of cog-
nitive reserve that help individuals acquire and use the set
of skills necessary to cope with pathology and, therefore,
perform normally on cognitive tasks. In this study, we chose
to estimate cognitive reserve using a word-reading estimate
of premorbid ability, namely theAMNART (Ryan & Paolo,
1992). TheAMNART is a reading list of 50 irregular words
that are scored correct if pronounced accurately. IQ is deter-
mined based on an error score. Numerous studies found
pronunciation accuracy to correlate highly with measured
intelligence on the Wechsler Adult Intelligence Scale-
Revised Verbal IQ (WAIS-R VIQ; r5.80 to .95; Friedman
et al., 1992; Nelson & O’Connell, 1978; Ryan & Paolo,
1992; Wiens et al., 1993), and it has shown adequate relia-
822 D.M. Rentz et al.bility and stability in healthy elders and questionable0mild
dementia when used in a longitudinal epidemiological study
(Schmand et al., 1998). Although some studies have suc-
cessfully used a combination of factors to constitute a cog-
nitive reserve index (Stern et al., 2005), we chose a single
measure of premorbid IQ because other studies found this
method more sensitive to the neurophysiological effects of
AD than other demographic variables (Alexander et al.,
Table 1. Baseline and follow-up data for IQ-MN and IQ-MI groups
Normative
Cutoff
IQ-Adj.
Cutoff
IQ-MN
N 5 13
IQ-MI
N 5 10
Gender p value
Male 6 3 .45
Female 7 7
Demographics MS DMS D
Age 69.3 4.8 71.8 4.2 .21
Years of education 17.0 2.4 14.7 2.9 .06
AMNART IQ 127.4 3.5 124.9 3.9 .13
GDS 2.9 2.5 3.7 3.0 .46
Blessed IMC .38 .7 .60 .7 .45
Cognitive tests
FAS
Baseline ,31 ,44 46.2 12.0 48.9 10.8 .57
Follow-up 56.2 15.8 47.5 12.5 .17
CAT
Baseline ,38 ,50 51.1 4.6 50.0 5.8 .63
Follow-up 53.2 6.4 48.6 7.6 .13
BNT
Baseline ,44 ,55 57.7 2.1 56.3 2.5 .16
Follow-up 58.5 1.4 57.2 2.7 .16
VFDT
Baseline ,25 ,29 31.0 .9 30.5 1.4 .30
Follow-up 31.6 .7 29.3 3.1 .01*
SRT-TR
Baseline ,33 ,47 51.2 5.7 44.1 5.9 .01*
Follow-up 53.2 7.4 40.7 6.3 .00*
SRT-LTS
Baseline ,22 ,42 44.7 11.8 30.4 9.5 .01*
Follow-up 45.5 11.5 24.7 10.5 .00*
SRT-LTR
Baseline ,18 ,37 42.0 10.9 27.7 9.0 .00*
Follow-up 43.6 11.8 22.2 9.2 .00*
SRT-CLTR
Baseline ,4 ,24 35.2 11.6 24.0 8.7 .02*
Follow-up 36.5 13.1 13.9 9.6 .00*
SRT-DR
Baseline ,3 ,7 8.2 2.0 5.5 2.2 .01*
Follow-up 8.6 2.0 5.7 1.6 .00*
SRT-DR30
Baseline ,3 ,7 9.0 1.9 6.9 2.5 .03*
Follow-up 9.3 1.8 6.6 2.1 .00*
SRT-MC30
Baseline ,11 ,11 11.8 .6 11.1 .7 .01*
Follow-up 12.0 .0 11.5 .7 .02*
Note.M N5 memory normal; MI 5 memory impaired; AMNART 5 American National Adult Reading Test estimated Verbal IQ;
GDS 5 Geriatric Depression Scale; IMC 5 Information, Memory, and Concentration subtest of the Blessed Dementia Rating Scale;
FAS 5 word generation to the letters F, A, and S; CAT 5 Word generation to the categories animals, vegetables, and fruits; BNT 5
Boston Naming Test; VFDT5Visual Form Discrimination Test; SRT5Selective Reminding Test; TR5Total Recall on SRT; LTS5
Long-Term Storage on SRT; LTR5 Long-Term Retrieval on SRT; CLTR5 Continuous Long-Term Retrieval on SRT; DR5 10-min
Delayed Recall on the SRT; DR30 5 30-min Delayed Recall on the SRT; MC30 5 30-min Recognition on the SRT. *p , .05. Cutoff
scores were calculated at 1.5 SD below the mean and the normative reference groups were as follows: FAS and CAT (Monsch et al.,
1992), BNT (Tombaugh and Hubley, 1997), VFDT (Benton et al., 1983), and SRT (Masur et al., 1989).
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variables (Bright et al., 2002). Also, an IQ estimate pro-
poses to index higher levels of native ability when subjects
do not have the advantages of education (Satz, 1993;
Schmand et al., 1997). In a previous study, we explored
whether education-adjustments were equally predictive of
progression to MCI as IQ-adjustments, and found that
education-adjustments were 8.8 times less sensitive at pre-
dictingprogressiontoMCIthanIQ-adjustments(Rentzetal.,
2004). This finding was due to the fact that many of the
women in this aged cohort had superior levels of premorbid
intelligence but were not well educated. However, we rec-
ognize that use of the AMNART as a proxy of cognitive
reserve is not perfect for all subjects, particularly those
with reading difficulties or non-English speaking partici-
pants (O’Carroll, 1995; Storandt et al., 1995). Therefore,
all participants in this study were English speaking and had
no history of learning disabilities.
At entry, test scores were adjusted for IQ in the following
manner: the “mean” value of the published norms was raised
to match the individual’s IQ level in a method previously
described (Rentz et al., 2004). Adjustments were based on
the WAIS-R IQ standardization sample in which the mean
IQ of the population is 100 and the standard deviation is 15.
IQ scores that were between 120 and 129 are approximately
1.7 SD above the population mean of 100. IQ scores that
were equal to or greater than 130 are approximately 2 SD
above the mean. If the estimated AMNART IQ was  120
but 129, the normative mean was adjusted upward by 1.7
SD and a new adjusted mean was established for this IQ
range. If the estimated AMNART IQ was  130, the nor-
mative mean was adjusted upward by 2 SD and a new
adjusted mean was established for this IQ range. Since
Petersen et al. (1999) demonstrated that a 1.5 SD cutoff
below age-appropriate mean scores accurately predicted
decline to AD, we applied this 1.5 SD below the mean cut-
off to our IQ-adjusted norms to designate an abnormal score.
The cutoff scores used in this study were identical to those
previously reported (Rentz et al., 2004).
Based on normal or abnormal test performances adjusted
for IQ, subjects were placed into one of two groups: IQ-MN
(memory normal), those subjects who scored in the normal
range for IQ across all tests and were predicted to remain
stable over 3 years; IQ-MI (memory impaired), those sub-
jects who scored in the abnormal range for IQ on at least
one subtest of the SRT, scored normally for their ability on
all other tests of attention, executive function (i.e., word
fluency, language, and visuospatial perception), and were
predictedtodeclineover3years.WeselectedIQ-adjustments
in memory only because memory is the earliest symptom of
prodromal AD and the SRT has been shown to be a partic-
ularly sensitive indicator of subtle impairment that is pre-
dictive of decline over time (Hall et al., 2000; Masur et al.,
1990). We also controlled for the potential of intraindivid-
ualvariabilityinneuropsychologicalperformancebyinclud-
ing only those subjects who scored within 1.5 SD from the
mean on all cognitive tasks except memory. None of the
subjects in this study had a diagnosis of dementia, even in
the earliest stages.
After IQ-adjustments, 10 of the 23 subjects were reclas-
sifiedasmemoryimpaired(IQ-MI)and13subjectsremained
within the normal range (IQ-MN). There were no statisti-
cally significant differences between groups in age, educa-
tion,estimatedAMNARTIQ,GDS,orInformation,Memory,
and Concentration subtest of the Blessed Dementia Rating
Scale (see Table 1).
A total of 5 of the IQ-MN and 5 of the IQ-MI subjects
demonstrated minimal or mild increased T2 signal in white
matterconsistentwithsmallvesselcerebrovascularchanges.
None of the subjects had evidence of large vessel infarcts or
other structural lesions. Mild atrophy was noted on the clin-
ical read in 2 of the IQ-MN and 2 of the IQ-MI subjects.
Subjects underwent annual neuropsychological evalua-
tions for 3 years. A reliable informant, who lived with or
near the subject was also administered a structured inter-
view as part of the CDR (Morris, 1993).
The primary variable of interest was pattern of SPECT
perfusion at baseline. The secondary variable of interest
wasdegreeofcognitiveandfunctionaldeclinefrombaseline.
SPECT Image Acquisition
Images were acquired 20 min after intravenous injection of
20 6 1 mCi of 99mTc-HMPAO (Ceretec, GE-HealthCare,
UK), injected into a previously placed intravenous line with
the subject supine at rest, with eyes open, in a darkened
room, and with ambient white noise. SPECT images were
obtained with the Ceraspect brain camera (Digital Scinti-
graphics, Inc., Waltham, MA), which consists of a single
annular sodium iodide crystal and a rotating parallel hole
collimator. Spatial resolution is 8.2 mm full width at half-
maximum (FWHM) at the center of the field of view for
99mTc. The acquisition time was 15 s per projection for a
total acquisition time of 30 min. Data sets were corrected
for attenuation and reconstructed with filtered back-
projection, using a Butterworth filter.
Data Analysis
Image analysis
SPECT data were analyzed using a voxel-based univariate
method, Statistical Parametric Mapping (SPM2, Wellcome
Department of Cognitive Neurology, Functional Imaging
Laboratory, London; Friston et al., 1995). Each data set was
spatiallytransformedtotheSPMSPECTtemplate,smoothed
with a 12 mm FWHM Gaussian kernel, and proportionally
scaled to the mean global voxel value. To minimize edge
effects, voxels with values less than 80% of the whole brain
mean were excluded.Two-sample t tests (contrasting IQ-MI
with IQ-MN, no covariates) were performed in both posi-
tive and negative directions (i.e., contrasts 1, 21, and 21, 1)
toidentifybothincreasesanddecreasesinrelativeperfusion.
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(uncorrected) were identified in terms of voxel coordinates
atthepeaksignificancelevelandlabeledaccordingtoTalair-
ach and Tournoux (Talairach & Tournoux, 1988) after con-
version from SPM space (i.e., Montreal Neurological
Institute space), using the linear transformations of Brett
(www.mrc-cbu.cam.ac.uk0Imaging; Brett et al., 2002).
Regions that met the threshold of significance and exceeded
200 voxels in extent were identified by comparing cluster
location with a probabilistic atlas (Lancaster et al., 2000).
Neuropsychological analysis
StatisticalanalyseswereperformedusingSPSSversion11.5.
All tests were two-tailed, with statistical significance set at
a5.05. Independent-samples t tests were used to measure
differences between groups on demographic variables at
baselineandneuropsychologicaltestsatbaselineandfollow-
up. Change scores were derived from converting raw scores
to Z scores and subtracting the difference between follow-up
performancesfrombaselineperformances.Independentsam-
ple t tests explored differences in change scores between
IQ-MN and IQ-MI groups.
RESULTS
Neuropsychological Results
Group differences at baseline
When IQ-adjusted norms were applied, 10 subjects were
designated as IQ-MI and 13 subjects remained as IQ-MN.
The mean raw scores of the IQ-MN and IQ-MI groups dif-
fered significantly on all SRT memory measures including
Total Recall [TR; t(1,21) 5 2.903; p 5 .008], Long-Term
Storage [LTS; t(1,21) 5 3.117; p 5 .005], Long-Term
Retrieval[LTR;t(1,21)53.363;p5.003],ConsistentLong-
Term Retrieval [CLTR; t(1,21)52.538; p5.019], 10-min
Delayed Recall [DR; t(1,21) 5 3.122; p 5 .005], 30-min
Delayed Recall [DR30; t(1,21) 5 2.278; p 5 .033], and
Recognition Recall [MC30; t(1,21) 5 2.773; p 5 .011].
There were also no significant differences between groups
onotherneuropsychologicaltests,includingFAS,CAT,BNT,
or on the VFDT (see Table 1).
Group differences at follow-up
Three years later, IQ-MN and IQ-MI groups again differed
significantly on all SRT memory measures, including TR
[t(1,21) 5 4.278; p 5 .000], LTS [t(1,21) 5 4.452; p 5
.000], LTR [t(1,21) 5 4.478; p 5 .000], CLTR [t(1,21) 5
4.451; p 5 .000], DR [t(1,21) 5 3.819; p 5 .001], DR30
[t(1,21) 5 3.274; p 5 .004], and MC30 [t(1,21) 5 2.568;
p5.018].Inaddition,asignificantdifferencebetweengroups
was observed on the VFDT [t(1,21) 5 2.671; p 5 .014].
There were no significant differences between groups in
word fluency, category generation, or naming (seeTable 1).
Change score group differences at follow-up
Independent samples t tests of Z change scores revealed
IQ-MI subjects statistically declined from baseline over 3
yearsincontrasttoIQ-MNsubjects.Thesedeclinesoccurred
on tests of memory for TR [t(1,21)5 2.155; p 5 .043] and
CLTR [t(1,21) 5 2.758; p 5.012] but not LTS, LTR, DR,
DR30, or MC30. Significant change was also observed on
FAS [t(1,21)52.695; p 5.014], with IQ-MN subjects dem-
onstrating a significant improvement in performance in con-
trast to IQ-MI and on VFDT, with IQ-MI doing worse
[t(1,21) 5 2.237; p 5.014]. There were no significant dif-
ferences noted on CAT or the BNT (see Figure 1).
Clinical outcome
CDR scores at 3-year follow-up revealed that, within the
IQ-MI group, 6 of 10 IQ-MI subjects declined functionally
from a CDR of 0 to a CDR of 0.5 in the memory box score,
resulting in a CDR total score of 0.5.All 13 subjects within
the IQ-MN group maintained a CDR of 0. Thus, a signifi-
cantly greater proportion (60%) of individuals identified as
at-risk (IQ-MI) declined, compared to (0%) of IQ-MN sub-
jects [x2(1, n 5 23) 5 10.55; p 5 .001].
SPECT Results
Perfusion was significantly reduced in IQ-MI compared to
IQ-MN subjects in a large right inferior parietal, superior
temporal, insular, and opercular frontal region (2024 vox-
els, nearest BA 1302204006044, p , .008, corrected for
multiple comparisons at the cluster level), a right precuneus
region(216voxels,BA7),andarightinferiorparietalregion
(239 voxels, BA 39040; see Table 2 and Figure 2). Smaller
clusters of reduced perfusion that did not reach the planned
significance threshold were seen in contralateral homolo-
gous regions and included left precuneus (Z 5 2.96; p ,
.002, 103 voxels, BA7) and left inferior parietal (Z 5 2.84;
p , .002, 109 voxels, BA 40). Perfusion was significantly
increased in a left medial frontal, rostral anterior cingulate
region (BA11012032; p,.004, corrected for multiple com-
parisons) with the IQ-MI compared to the IQ-MN group
(see Table 2 and Figure 2).
DISCUSSION
The cognitive reserve hypothesis suggests that highly intel-
ligent individuals with the beginnings ofAD pathology may
not exhibit cognitive impairment, making the diagnosis of
earlyAD difficult. In this study, we explored whether mak-
ing IQ-adjustments was useful in detecting memory impair-
ments in subjects with high cognitive reserve and whether
these memory impairments were associated with SPECT
perfusion abnormalities at baseline. We found that using an
IQ-adjustment method to account for cognitive reserve in
CDR0 subjects was able to identify a subset of individuals
with subtle memory impairment who showed evidence of
IQ-MI and SPECT perfusion 825cerebral dysfunction on SPECTat baseline in a pattern con-
sistent with AD. These subjects were also more likely to
demonstrate subsequent cognitive and functional decline
than those without IQ-adjusted abnormalities.
More specifically, IQ-adjustments revealed memory
impairment in verbal learning and memory retrieval in 10
CDR0subjects.Severalotherlongitudinalstudiesalsofound
that early declines in memory acquisition and retrieval were
predictive of conversion to AD (Albert et al., 2001; Collie
et al., 2001; Petersen et al., 1994; Stern et al., 1999; Stern-
berg et al., 2001) and have long been associated with the
temporolimbic amnesia commonly found in AD (Albert
et al., 2001; Cooper et al., 2004; Monsch et al., 1992; Rentz
& Weintraub, 1999). Three years later, all 10 subjects with
Fig. 1. Z score change from baseline on cognitive tests. Mean Z score changes (6 SE) for word generation to the
letters F, A, and S (FAS); category generation to animals, vegetables, and fruit (CAT); Boston Naming Test (BNT);
Visual Form Discrimination Test (VFDT); and Selective Reminding Test: Total Recall (TR), Long-Term Store (LTS),
Long-Term Retrieval (LTR), Continuous Long Term Retrieval (CLTR), 10-min Delayed Recall (DR), 30-min Delayed
Recall (DR30), and 30-min Recognition Recall (MC30). Individuals designated as IQ-MI (memory impaired) dem-
onstrated statistically significant changes in phonemic fluency (FAS), visuospatial processing (VFDT), and memory
learning (TR) and retrieval (CLTR) compared to the IQ-MN (memory normal) group. *p , .05.
Table 2. Brain areas with significantly different perfusion in IQ-MI subjects compared
to IQ-MN subjects
Extent
(voxels)
Z
score
p ,
(uncorrected)
x,y,z
coordinates Region BA
Perfusion decrease
2024 4.47 .000004* 44, 2, 22 Rt. Insula0
Sup. Temporal0
Inf. Parietal0
Inf. Frontal0
130
220
400
6044
216 3.74 .0001 24, 271, 52 Rt. Precuneus 7
239 3.38 .0004 44, 235, 33 Rt. Inf. Parietal 39040
Perfusion increase
2267 4.56 .000002** 212, 24, 210 Lt. Ant.
Cingulate0
Frontal-subcallosal
110
120
32
Note. Perfusion decreases and increases are listed with the corresponding cluster size (extent in voxels),
peak voxel Z score, p value (voxel level, uncorrected), peak voxel coordinates, anatomic label, and
nearest Brodmann area(s). MI5memory impaired; MN5memory normal; BA5Brodmann area; Rt.5
right; Sup. 5 superior; Inf. 5 inferior; Lt. 5 left; Ant. 5 anterior. *p 5 .008 at the cluster-level,
corrected. **p 5 .004 at the cluster-level, corrected.
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nificant decline in memory, particularlyTR and CLTR com-
pared to IQ-MN. In addition, over half of the IQ-MI subjects
also declined in functional status on informant report,
whereas none of the IQ-MN subjects declined.
Some may argue that the selective reminding procedures,
as used in this study, are not comparable to other measures
of episodic memory, because they rely on feedback that is
tailored to the individual, that is, only a portion of the list
that was not immediately recalled is presented for learning.
Therefore, decline on the SRT may be related to executive
compromise and not exclusively to the ability to remember
words (Loring & Papanicolaou, 1987). However, in prodro-
mal AD, early executive compromise has been noted by
others (Albert et al., 2001) and may explain why SRT pro-
cedures were useful in distinguishing our CDR0 subjects
who subsequently declined. It is possible that cognitive
reserve may modulate aspects of executive function that are
beneficial to memory processing during the SRT. However,
it would be helpful, in future studies, to make a comparison
between episodic learning paradigms and SRT procedures
todeterminewhichmeasuresprovidegreaterpredictiveabil-
ity in subjects with high cognitive reserve.
Various proxy measures of cognitive reserve have been
explored in several studies, including demographic based
regression estimations (Barona et al., 1984), level of edu-
cation, word reading estimates of premorbid IQ, and more
recently,variouscombinationsofeducation,occupation,and
IQ (Andel et al., 2006; Stern et al., 1994, 1995, 2005). In
this study, we chose to estimate cognitive reserve using the
AMNART, in part because other studies found word-
reading estimates of premorbid IQ more sensitive to the
neurophysiological effects of AD than other demographic
variables (Alexander et al., 1997) or a combination of vari-
ables (Bright et al., 2002). However, it is important to note
that using an estimate of premorbid ability as a baseline
from which to measure impairment presumes that individ-
uals perform at a consistent level across all cognitive
domains.Although this is a standard theoretical assumption
in neuropsychology (Filskov & Leli, 1981), there is a poten-
tial limitation in interpreting low average neuropsycholog-
ical test performances as abnormal in persons with superior
premorbid ability (Diaz-Asper et al., 2004) and using pre-
morbid IQ as an estimate of premorbid memory (Schretlen
etal.,2005).Schretlenetal.(2005)reportedthatIQaccounts
for only 16–28% of the variance in memory, but this num-
ber is based on a cross-section of the age span and may not
fully reflect the impact of cognitive reserve on memory in
older individuals. As memory declines with aging and AD
pathology, it is likely that individuals need to rely more on
compensatory encoding and retrieval strategies, which may
be augmented by cognitive reserve. Our study suggests that
IQ adjustment of memory scores as a proxy of cognitive
reserve may provide a useful way to identify individuals at
higher risk for subsequent cognitive decline.
AlthoughweusednormativedatafromMasuretal.(1989)
to identify normal memory performance in older individu-
als, it is important to note that the normative sample from
Masur et al. (1989) was older than our sample and much
less educated. If more demographically appropriate norms
were available, it is possible that our IQ-MI subjects would
have been identified as impaired without the use of IQ-
adjustments.However,allofoursubjectswereCDR0,mean-
ing that they were functioning normal in everyday life and
were not clinically impaired.
Moreover, there has been recent discussion as to what
cutoff threshold is more sensitive at predicting conversion
toAD in at-risk individuals. Petersen et al. (1999) suggests
a cutoff of 1.5 SD below the mean to designate memory
impairment. Busse et al. (2006) reported cutoff scores at 1
SD below the mean were more sensitive in detecting sub-
jects who later converted toAD. It is possible that adjusting
the cutoff thresholds might improve the ability to detect
early memory changes in subjects with high cognitive
reserve. Future studies exploring various methodologies for
accounting for cognitive reserve would be helpful, includ-
ing more sensitive cutoff scores, IQ-adjustments, or devel-
oping more contemporary norms.
TheIQ-MIsubjectswhoscoredgreaterthan1.5SDbelow
the mean for their ability on measures of memory at base-
line demonstrated continued decline 3 years later in con-
trast to IQ-MN subjects who tended to show improvement.
We have previously reported that improvement in cognitive
test scores is commonly seen among normal controls (Rentz
Fig. 2. Lower perfusion in IQ-MI (memory impaired) subjects compared to IQ-MN (memory normal) subjects in
parietal0precuneus, temporal, and opercular frontal are shown in posterior (A), right lateral (B), and superior (C)
surface projections. Higher perfusion in IQ-MI compared to IQ-MN is shown in the left medial surface projection (D).
IQ-MI and SPECT perfusion 827et al., 2004) and may be due to a practice effect. However,
many individuals at-risk for AD do not seem to benefit
from practice and demonstrate decline over time. In our
sample, these declines were primarily in memory and cor-
respond to the fact that the CDR scores of 6 of 10 IQ-MI
subjects demonstrated functional decline related to mem-
ory. These findings suggest that IQ-adjustments in memory
used to account for cognitive reserve show promise in being
able to identify CDR0 subjects who are at risk for both
cognitive and functional decline.
Finally, we were interested in learning whether subjects
who demonstrated memory impairment for their ability
showed abnormalities in functional imaging that were con-
sistentwithMCIandAD.UsingperfusionSPECT,wefound
regional functional abnormalities in IQ-MI subjects at base-
line in a temporoparietal distribution that is similar to the
distributionreportedinMCIsubjectswhosubsequentlycon-
verted to AD (Chetelat et al., 2003; Johnson et al., 1998).
Similar findings have also been reported in mildAD (John-
sonetal.,2001).Morerecently,evidenceofearlyADpathol-
ogy in these regions was confirmed among MCI patients
who came to autopsy (Bradley et al., 2002; Markesbery
et al., 2006; Petersen et al., 2006). The temporoparietal per-
fusion abnormalities noted in our IQ-MI subjects at base-
line suggest that AD pathology may have been present at
the time of initial evaluation in normal CDR0 subjects. All
of our IQ-MI subjects had the apolipoprotein E303 geno-
type, as we intentionally excluded subjects with the E4 and
E2 allele. Interestingly, the pattern of SPECT hypoperfu-
sionshowedseveraloverlappingregionswiththosereported
in genetic at-risk subjects (Caselli et al., 2004; Reiman et al.,
2001, 2005; Small, 2002); however, the presence of an E4
allele could not explain our findings.
We also found a ventral anterior cingulate region of
increased perfusion in IQ-MI subjects compared to IQ-MN
subjects. This finding is similar to one we recently reported
in CDR 0.5 subjects who were followed and converted to
AD within 5 years (Johnson et al., 2007). The increased
perfusion in this region might reflect a compensatory
response arising along the early trajectory ofAD in response
to encroaching pathologic involvement.
It is possible that our SPECT findings were partly due to
regional atrophy occurring in IQ-MI subjects, and a limita-
tion of this study is that we did not have complete high-
resolution brain structural data available to fully assess this
possibility. We also realize that this study involved a rela-
tively small number of subjects and may limit the general-
izability of our findings.
Insummary,weusedanIQ-adjustmentmethodtoaccount
for cognitive reserve in a highly intelligent sample of older
individuals. We found that IQ-adjustments identified early
memory changes associated with SPECT hypoperfusion in
apatternconsistentwithADandpredictedsubsequentfuture
decline.Asdisease-modifyingtreatmentsandimagingmark-
ers to detect pathological changes in vivo are entering clin-
ical trials, the accurate identification of individuals at high
risk for developing AD is vital. The findings of this study
suggest that neuropsychological methods, which account
for cognitive reserve, may improve the ability to identify
at-risk individuals with pathological memory changes that
portend the trajectory toward AD.
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